Scholars Central

Review articlePublished 27 Dec 2021

Diabetic related cardiomyopathy, pathophysiology, diagnosis and potential treatments

Authors: Hanan B. Al Backr

Clinical Cardiology Journal

Volume 6 · Issue 1 · Pages 1–20

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Patients with diabetes mellitus show an increased incidence of heart failure (HF) even after adjustment for well-established risk factors for HF such as hypertension and ischemic heart disease. The resulting specific form of cardiomyopathy is known as diabetes mellitus -related cardiomyopathy” (DMCM). Pathogenic mechanisms underlying DCM are likely to be multifactorial from altered myocardial metabolism (hyperglycemia, hyperinsulinemia, increased circulating fatty acids and triglycerides) to microvascular disease, and altered myocardial structure with fibrosis. Current guidelines recommendations for medical treatment on HF in patients with diabetes mellitus (DM) do not differ from those for patients without DM. Regarding the effect of different hypoglycemic drugs on HF in patients with DM, and considering the best available current evidence, the sodium-glucose-co-transporter 2 inhibitors and metformin seem to be especially effective in patients with T2D and HF.

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Cardiology Journal.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Cardiology Journal
  • SubjectCardiology
  • BylineArticles whose byline prints “Hanan B. Al Backr”